Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer.

Cruz VH, Arner EN, Du W, Bremauntz AE, Brekken RA.

JCI Insight. 2019 Apr 2;5. pii: 126117. doi: 10.1172/jci.insight.126117.

2.

Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.

Cruz VH, Arner EN, Wynne KW, Scherer PE, Brekken RA.

Mol Metab. 2018 Oct;16:139-149. doi: 10.1016/j.molmet.2018.06.007. Epub 2018 Jun 11.

3.

Assessment of TANK-binding kinase 1 as a therapeutic target in cancer.

Cruz VH, Brekken RA.

J Cell Commun Signal. 2018 Mar;12(1):83-90. doi: 10.1007/s12079-017-0438-y. Epub 2017 Dec 7. Review.

4.

Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.

Ludwig KF, Du W, Sorrelle NB, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RA.

Cancer Res. 2018 Jan 1;78(1):246-255. doi: 10.1158/0008-5472.CAN-17-1973. Epub 2017 Nov 27.

5.

Effect of prior warm-up duration on the time limit at peak speed in untrained men.

da Cruz VH, Peserico CS, Machado FA.

J Sports Med Phys Fitness. 2017 Oct;57(10):1276-1281. doi: 10.23736/S0022-4707.17.06810-4. Epub 2017 Jan 23.

PMID:
28116878
6.

Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis.

Guo Y, Updegraff BL, Park S, Durakoglugil D, Cruz VH, Maddux S, Hwang TH, O'Donnell KA.

Cancer Res. 2016 Feb 15;76(4):773-86. doi: 10.1158/0008-5472.CAN-15-1697. Epub 2015 Dec 16.

7.

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.

Ocal O, Pashkov V, Kollipara RK, Zolghadri Y, Cruz VH, Hale MA, Heath BR, Artyukhin AB, Christie AL, Tsoulfas P, Lorens JB, Swift GH, Brekken RA, Wilkie TM.

Dis Model Mech. 2015 Oct 1;8(10):1201-11. doi: 10.1242/dmm.020933.

Supplemental Content

Support Center